Dissolution Test Apparatus for Tablets

Dissolution Test Apparatus for tablets is a key instrument in pharmaceutical quality control. It measures the rate and extent of drug release (dissolution) from solid oral dosage forms like tablets and capsules into a dissolution medium, simulating gastrointestinal conditions. This helps predict bioavailability, ensure batch consistency, and meet regulatory standards (e.g., USP, Ph. Eur., IP).

Common USP Apparatus for Tablets

Pharmacopeias like the USP define standardized apparatus. The most relevant for tablets are:

1. USP Apparatus 1 (Basket Apparatus)
   • A cylindrical stainless steel wire mesh basket rotates in a 500–1000 mL glass vessel.
   • Typical use: Capsules, floating tablets, or dosage forms that tend to float/stick. Also for some extended-release products.
   • Speed: Usually 50–100 rpm.
   • Temperature: 37 ± 0.5°C.
2. USP Apparatus 2 (Paddle Apparatus) — Most common for tablets
   • A paddle blade (often coated) rotates in a similar vessel. The tablet is dropped directly into the medium.
   • Typical use: Immediate-release tablets, many conventional solid oral dosage forms.
   • Speed: Commonly 50 rpm (or 25–75 rpm depending on the monograph).
   • Preferred for rapidly disintegrating tablets due to gentle hydrodynamics.

Other apparatus (less common for standard tablets but used in specific cases):

• USP Apparatus 3 (Reciprocating Cylinder): For extended-release or chewable tablets; simulates changing GI pH.
• USP Apparatus 4 (Flow-Through Cell): For poorly soluble drugs or modified-release; continuous flow of fresh medium.
• USP Apparatus 5 (Paddle over Disk) and 6 (Rotating Cylinder): Mainly for transdermal patches or special forms.
• USP Apparatus 7 (Reciprocating Holder): For controlled-release or small dosage forms.

Key Components of a Typical Dissolution Tester

• Vessels: Borosilicate glass (usually 1 L), hemispherical bottom.
• Stirring element: Basket or paddle.
• Heater: Water bath or jacket maintains 37 ± 0.5°C.
• Sampling: Manual or automated probes/filters for withdrawing samples at intervals.
• Controls: Speed (rpm), time, temperature monitoring; modern units have touchscreen interfaces and data logging.
• Many systems support 6–8 vessels for simultaneous testing.

Procedure Overview (for Apparatus 1 or 2)

• Add degassed dissolution medium (e.g., 900 mL water, buffer, or surfactant solution per monograph).
• Equilibrate to 37°C
• Introduce the tablet (in basket for App. 1; directly for App. 2).
• Start rotation.
• Withdraw samples at specified times, filter, analyze (UV, HPLC, etc.).
• Compare % drug dissolved vs. acceptance criteria (e.g., Q value at a specific time

Sinkers (e.g., platinum wire coils) may be used if tablets float.

Regulatory Aspects

Tests must comply with USP <711> Dissolution or equivalent. Apparatus must be qualified (mechanical calibration + performance verification with USP calibrators). Factors like medium pH, volume, agitation speed, and deaeration significantly affect results.